Current stock page

Financial Data

IRON Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

IRONDisc Medicine, Inc.

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$80.00−$3.23 (−3.88%)

Latest quote

  • Momentum
    75
  • Value
    —
  • Quality
    60
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$0$0$0$0$0$0$0$0
Gross Profit$0$0$0$0$0$0$0$0
Operating Income-$64.16M-$65.08M-$69.52M-$66.97M-$67.7M-$61.41M-$39.95M-$34.55M
Net Income-$59.54M-$59.53M-$63.5M-$60.53M-$62.32M-$55.25M-$34.09M-$29.46M
EPS-$1.53-$1.54-$1.65-$1.64-$1.77-$1.58-$1.02-$0.98
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$40.2M-$44.2M-$62.24M-$43.3M-$47.8M-$47.92M-$41.38M-$27.57M
Capital Expenditure$0$0$0-$20K-$26K-$36K-$851K-$449K
Free Cash Flow-$40.2M-$44.2M-$62.24M-$43.32M-$47.83M-$47.95M-$42.23M-$28.02M
Net Cash Provided By Operating Activities-$40.2M-$44.2M-$62.24M-$43.3M-$47.8M-$47.92M-$41.38M-$27.57M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$699.49M$735.07M$750.21M$806.88M$630.46M$665.06M$709.27M$496.77M
Total Debt$61.09M$60.86M$31.06M$1.86M$30.98M$30.92M$30.64M$30M
Cash And Cash Equivalents$89.98M$98.68M$88.91M$91.15M$140.66M$127.34M$122.68M$192.43M
Total Liabilities$95.24M$90.91M$61.78M$67.05M$57.07M$50.9M$48.9M$53.19M
Total Stockholders Equity$604.25M$644.16M$688.43M$739.83M$573.39M$614.17M$660.36M$443.59M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio5.084.763.923.055.34———
P/S ratio————————
Debt To Equity0.10.090.0500.050.050.050.07
Free Cash Flow Yield-6.19%-6.45%-7.47%-8.03%-5.42%———
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio5.084.763.923.055.34———
P/S ratio————————
Return On Equity-40.23%-38.17%-35.09%-28.68%-31.59%-23.67%-17.64%-24.65%
Debt To Equity0.10.090.0500.050.050.050.07

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-12.58x
Pb5.15x
EPS Growth Yoy13.56%
Gross Margin0.00%
Operating Margin0.00%
ROE-36.33%
ROIC-39.94%
Debt To Equity0.1
FCF Yield-6.18%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$80.00
Volume779,947
RSI (14)54.17
MACD3.56
MACD signal3.55
MACD histogram0.01
ADX (14)36.74
SMA (50)$71.59
SMA (200)$70.95
ATR (14)$4.10
Historical volatility (annualized)146.77%
Volume (20-day average)1.71M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score51/100
Beta0.99
Annual volatility63.55%
Max Drawdown-40.77%
Sharpe Ratio0.1
VaR (95%, 1-day)-4.40%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

IRON Financial Data FAQ

What is Disc Medicine, Inc.'s revenue?

Disc Medicine, Inc.'s revenue is one of the core financial data points for IRON. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Disc Medicine, Inc.'s revenue growing?

Revenue growth shows whether Disc Medicine, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is IRON's EPS?

IRON's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Disc Medicine, Inc.'s net income?

Disc Medicine, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Disc Medicine, Inc. generate?

Free cash flow shows how much cash Disc Medicine, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Disc Medicine, Inc. have?

Cash and debt help frame IRON's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.